Colonic wall thickening is related to age and not dose of high strength pancreatin microspheres in children with cystic fibrosis

European Journal of Gastroenterology and Hepatology

Volumn 11, Issue 2, 1999, Pages 181-183

  Connett, Gary J ^a   Lucas, Jane S ^a   Atchley, Julian T M ^a   Fairhurst, Joanna J ^a   Rolles, Chris J ^a  

^a UNIVERSITY HOSPITAL SOUTHAMPTON NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

Cystic fibrosis; Fibrosing colonopathy; Pancreatic microspheres

Indexed keywords

KREON; MICROSPHERE; PANCREATIN; PROTEINASE; TRIACYLGLYCEROL LIPASE;

ADOLESCENT; AGING; ARTICLE; ASCENDING COLON; CHILD; CLINICAL ARTICLE; COLON DISEASE; COLON MUCOSA; CONTROLLED STUDY; CYSTIC FIBROSIS; DESCENDING COLON; DRUG MEGADOSE; FEMALE; HUMAN; INTESTINE WALL; MALE; NORMAL HUMAN; PREVALENCE; PRIORITY JOURNAL; THICKNESS; TRANSVERSE COLON; ULTRASOUND;

EID: 0032961438     PISSN: 0954691X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00042737-199902000-00020     Document Type: Article

References (14)

1. 1 Smyth RL, van Velzen D, Smyth AR, Lloyd DA, Heaf DP. Strictures of ascending colon in cystic fibrosis and high strength pancreatic enzymes. Lancet 994; 343:109.
2. 2 Smyth RL, Ashby D, O'Hea U, Burrows E, Lewis P, van Velzen D, Dodge JA, Fibrosing colonopathy in cystic fibrosis: results of a case-control study. Lancet 1995; 346:1247-1251,
3. 3 MacSweeney EJ, Oades PJ, Buchdahl R, Rosenthal M, Bush A. Relation of thickening of colon wall to pancreatic-enzyme treatment in cystic fibrosis, Lancet 1995; 345:752-756.
4. 4 Aibe T, Fuji T, Okita K, Takermoto T. A fundamental study of normal layor structure of the GI wall visualised by endoscopic ultrasonography. Scand J Gastroenterol 1986; 21(suppl 123):6-15.
5. 5 Calleti G, Cassanova P, Villanacci Grigioni W, Labo G. Problems and variations in interpretation of ultrasonic features of the normal upper and lower gastrointestinal tract wall. Scand J Gastroenterol 1986; 21(suppl 123):16-26.
6. 6 Committee on Safety of Medicines. Current problems in pharmacovigilance, London: Medicines Control Agency, 1994; 20:13.
7. 7 Borowitz DS, Grand RJ, Durie PR and the Consensus Committee. J Pediatr 1995; 127:681-684.
8. 8 Shwachman H. Gastrointestinal manifestations of cystic fibrosis. Pediatr Clin N Am 1975; 22:787-805.
9. 9 Hausler M, Biesterfield S, Duque D, Heimann G. Fibrosing colonopathy in an adult with cystic fibrosis: clinical, sonographic, and histological findings [Abstract], 22nd European CF Conference, Berlin, June 1998.
10. 10 Oades PJ, Bush A, Ong PS, Brereton RJ. High strength pancreatic enzyme supplements and large bowel stricture in cystic fibrosis. Lancet 1994; 343:109.
11. 11 Jones R, Franklin K, Spicer R, Berry J. Colonic strictures in children with cystic fibrosis on low-strength pancreatic enzymes. Lancet 1995; 346:499-500.
12. 12 van Velzon D. Colonic strictures in children with cystic fibrosis on low strength pancreatic enzymes. Lancet 1995; 346:500.
13. 13 van Velzen D, Ball LM, Dezfulian AR, Southgate A, Howard CV. Comparative and experimental pathology of fibrosing colonopathy. Postgrad Med J 1996; 72(suppl2):S39-S48.
14. 14 Bakowski M, Prescott P, Patterns of use of pancreatic enzyme supplements in fibrosing colonopathy: implications for pathogenesis. Pharmacoepidemiology & Drug Safety 1997; 6:347-358.